000 01409 a2200421 4500
005 20250512032027.0
264 0 _c19870304
008 198703s 0 0 eng d
022 _a0340-5761
024 7 _a10.1007/BF00316327
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJones, M M
245 0 0 _aControl of some aspects of cis-platinum nephrotoxicity.
_h[electronic resource]
260 _bArchives of toxicology
_cOct 1986
300 _a167-71 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aCarcinoma 256, Walker
_xdrug therapy
650 0 4 _aCisplatin
_xantagonists & inhibitors
650 0 4 _aDitiocarb
_xpharmacology
650 0 4 _aFemale
650 0 4 _aKidney Diseases
_xchemically induced
650 0 4 _aLeukocyte Count
_xdrug effects
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Inbred F344
650 0 4 _aRats, Inbred Strains
650 0 4 _aSorbitol
_xanalogs & derivatives
650 0 4 _aSpin Labels
650 0 4 _aStructure-Activity Relationship
650 0 4 _aThiocarbamates
_xpharmacology
700 1 _aBasinger, M A
700 1 _aCraft, W D
700 1 _aDomingo, J L
700 1 _aLlobet, J M
773 0 _tArchives of toxicology
_gvol. 59
_gno. 3
_gp. 167-71
856 4 0 _uhttps://doi.org/10.1007/BF00316327
_zAvailable from publisher's website
999 _c3034134
_d3034134